Clinical Trial Results
Revitive has been proven to increase circulation by up to 89%1.
People also experienced less pain while walking.
- Based on % change of arterial blood volume flow. During use in people with Peripheral Arterial Disease (PAD) at 6 weeks.
- When combining 30 mins daily use of Revitive with 60 mins of supervised exercise a week, over 6 weeks in people with PAD.
Clinical research studies to date
Ravikumar, R. et al.
Randomised Controlled Trial:Potential Benefit of a Footplate Neuromuscular Electrical Stimulation Device in Patients with Chronic Venous Disease. Eur. J. Vasc. Endovasc. Surg. 53, 114–121 (2017).
Ravikumar, R., Lane, T. R., Babber, A., Onida, S. & Davies, A. H.
A randomised controlled trial of neuromuscular stimulation in non-operative venous disease improves clinical and symptomatic status. Phlebol. J. Venous Dis. 36, 290–302 (2021).
Babber, A., Ravikumar, R., Williams, K. & Davies, A. H.
Neuromuscular Electrical Stimulation in the Management of Intermittent Claudication: A “Stimulating” Prospect. J. Vasc. Surg. 63, 16S-17S (2016).
Babber, A., Ravikumar, R., Onida, S., Lane, T. R. A. & Davies, A. H.
Effect of footplate neuromuscular electrical stimulation on functional and quality-of-life parameters in patients with peripheral artery disease: pilot, and subsequent randomized clinical trial. Br. J. Surg. 107, 355–363 (2020).
Statistical Analysis Report of Babber et al 2020
[On file at Actegy]
Save £10 on your first order
Never miss out on exclusive offers, advice & tips to help improve circulation